Advertisement
Canadian Journal of Cardiology

Patient Care Journey for Patients With Heart Valve Disease

Published:March 02, 2022DOI:https://doi.org/10.1016/j.cjca.2022.02.025
      Heart valve disease (HVD) is a common, serious, but treatable disease that affects more than 1 million Canadians. Too many people with HVD are receiving potentially life-saving treatments too late owing to a combination of low awareness, deficiencies in detection, and delays in diagnosis and unequal access to care.
      • Wijeysundera H.C.
      • Henning K.A.
      • Qiu F.
      • et al.
      Inequity in access to transcatheter aortic valve replacement: a pan-Canadian evaluation of wait-times.
      In response to these major gaps in care, Heart Valve Voice Canada, a patient advocacy organization—co-led by patient representatives, clinicians, and researchers—developed a report that describes what an optimal-care pathway should be for people living with HVD and provides a series of recommendations to improve the journey of these people.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wijeysundera H.C.
        • Henning K.A.
        • Qiu F.
        • et al.
        Inequity in access to transcatheter aortic valve replacement: a pan-Canadian evaluation of wait-times.
        Can J Cardiol. 2020; 36: 844-851
        • Botly L.C.P.
        • Lindsay M.P.
        • Mulvagh S.L.
        • et al.
        Recent trends in hospitalizations for cardiovascular disease, stroke, and vascular cognitive impairment in Canada.
        Can J Cardiol. 2020; 36: 1081-1090
        • Tarride J.E.
        • Lauck S.
        • Natarajan M.K.
        • Asgar A.W.
        • Luong T.
        • Blackhouse G.
        One-year costs associated with hospitalizations due to aortic stenosis in Canada.
        CJC Open. 2021; 3: 82-90
        • Otto C.M.
        • Nishimura R.A.
        • Bonow R.O.
        • et al.
        2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines.
        J Am Coll Cardiol. 2021; 77: 450-500
        • d'Arcy J.L.
        • Coffey S.
        • Loudon M.A.
        • et al.
        Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.
        Eur Heart J. 2016; 37: 3515-3522